
Harnessing the regenerative power of fat,
The largest source of stem cells.

Harnessing the unlimited power of fat,
The largest source of regenerative cells.
Sayenza Biosciences
Sayenza Bio is a leading clinical stage biotechnology company committed to improving patient lives by harnessing the regenerative power of fat, the body’s largest source of regenerative cells, for limitless aesthetic and regenerative medicine applications.
At Sayenza, our passionate, doctor-driven team unites cutting-edge scientific innovation with vast commercial expertise, propelling us towards transformative breakthroughs in healthcare.
THE POWER OF “LIQUID GOLD”
LIPOSUCTION
#1 procedure performed by plastic surgeons
Face Contouring
Fat, a healthier alternative to artificial fillers, is projected to tap into a market valued at $9B by 2028.
Breast Contouring
Fat, as a natural alternative to breast implants, is poised to disrupt a market expected to hit $4B by 2028.
Butt Lift
The hottest trend, powered by social media - revenue is forecasted to reach $6.6B by 2028.
REGENERATIVE THERAPY
Hair Restoration
Regenerating hair follicles, providing a novel solution for Alopecia.
Myocardium Restoration
Repairing heart tissue post-heart attack.
Nervous System Rebuilding
Restoring neural pathways, heralding breakthroughs in SCI and TBI treatment.
Skin Rejuvenation
Revitalizing aging skin, offering a natural route to youthfulness.
Wound Healing
Accelerating the healing of wounds, including diabetic foot ulcers.
Cartilage Repair
Repairing damaged cartilage, creating new hope for osteoarthritis patients.
Engineered for efficiency and precision, Sayenza’s automated, multifunctional device processes fat in under 15 minutes. Simultaneously, it creates a potent, ready-to-use therapeutic, for reinjection at the point of care.


Time
Consulting
Traditional fat processing can take up to 2 hours, reducing clinical efficiency.

Multistep/Manual Input
Manual, multistep procedures lead to inconsistent outcomes, compromising patient results.

Contamination
Risk
Multiple manual steps increase the chance of contamination, posing potential health risks.

Surgeon
Distraction
Labor-intensive processes divert surgeons' attention from primary patient care, impacting overall treatment quality.
Engineered for efficiency and precision, Sayenza’s automated, multifunctional device processes fat in under 15 minutes. Simultaneously, it creates a potent, ready-to-use therapeutic, for reinjection at the point of care.


Time
Consulting
Traditional fat processing can take up to 2 hours, reducing clinical efficiency.

Multistep/Manual Input
Manual, multistep procedures lead to inconsistent outcomes, compromising patient results.

Contamination
Risk
Multiple manual steps increase the chance of contamination, posing potential health risks.

Surgeon
Distraction
Labor-intensive processes divert surgeons' attention from primary patient care, impacting overall treatment quality.
Sayenza Bio is developing the industry’s first multi- functional automated platform that produces injectables for both fat grafting and regenerative therapy.

REGENERATIVE THERAPY












Reduced OR/procedure time

Allows processing small & large volumes

Reusable platform




Activated Regenerative Cell Therapeutic


Backed by:





“I am thrilled to join the board at Sayenza, a company that shares my passion for pioneering breakthroughs in regenerative medicine. Their dedication to harnessing the incredible potential of adipose-derived regenerative cells aligns perfectly with my own clinical expertise and commitment to transforming patient care. I believe that together, we can shape the future of regenerative therapies and create lasting, positive impacts on the lives of countless individuals.”
Dr. Ethan Kellum
Sports Medicine Orthopedic Surgeon
Nashville Regenerative Orthopedics
Former Assistant Team Physician for the Boston Celtics Clinical Advisory Board Member at Sayenza Biosciences
“We are thrilled to join the visionary team at Sayenza Biosciences, a company that is revolutionizing aesthetics and regenerative healthcare. We have spent our careers exploring the extraordinary potential of nanofat, and to see it being harnessed and magnified in such an innovative way is incredibly gratifying. It’s a new dawn in the field of regenerative medicine, and we are proud to be a part of this evolution, pushing the boundaries of what is possible.”
Drs. Patrick Tonnard and Alexis Verpaele
Co-inventors of nanofat

Get In Touch With Us Today
For any inquiries or information regarding our innovative regenerative medicine technologies, please contact us through the provided form or email.